Periop MI continues to be lethal

Data from the POISE trial shows that periop MI continues to carry 10-15% lethality, and that symptomatic MI may have worse outcome than symptomatic ones.

Also note that medical Rx after MI remains suboptimal.  Our decision analysis years ago supports the routine use of troponin to screen patients after open AAA surgery.

A slide show of salient data follows below:

One Response to “Periop MI continues to be lethal”

  1. […]  His work has continued to support perioperative beta blockade while other studies, such as POISE, have found adverse outcomes.  He is lead author of the European Society of Cardiologists […]

Leave a Reply